Triggering the autoimmune response against islets in type 1 diabetes
Diabetes mellitus is a medical disorder characterized by varying or persistent hyperglycemia (elevated blood sugar levels), especially after eating. Hyperglycemia itself can lead to dehydration and ketoacidosis. Longer-term complications include cardiovascular disease (doubled risk), chronic renal failure, retinal damage with eventual blindness, nerve damage, etc.
Triggering the autoimmune response against islets in type 1 diabetes

Diabetes :: Triggering the autoimmune response against islets in type 1 diabetes
Type 1A diabetes is an autoimmune disease that specifically affects beta cells within the pancreas and researchers have long asked why only certain organs are targeted in autoimmune disease.
In so-called NOD mice (an animal model of type 1 diabetes) T and B cells that infiltrate the pancreatic islets have been shown to target insulin B chain amino acids 9?23 (insulin B:9?23), and NOD mice lacking insulin B:9?23 are protected from diabetes.
This suggests that insulin, specifically the insulin B:9?23 sequence, may be essential for the initiation of spontaneous diabetes in NOD mice.
In the July 2 issue of the Journal of Clinical Investigation, George Eisenbarth and colleagues posed the question: In which tissue would expression of the native insulin sequence restore anti-insulin autoimmunity" The authors found that transplanted islet cells, but not bone marrow cells, expressing native B16:Y insulin (tyrosine at position 16 of insulin B chain) restored anti-insulin autoimmunity in mice that lacked native insulin genes. In addition, immunization with the native B16:Y insulin B:9?23 peptide, but not a mutated B16:A insulin B:9?23 peptide (alanine at position 16 of insulin B chain), rendered CD4+ T cells able to rapidly transfer diabetes to these animals when the recipient mouse also had the native B16:Y insulin B:9?23 sequence in its islets. The data demonstrate the dependence on just a single amino acid change (alanine versus tyrosine) in insulin B:9?23 for the development of anti-islet cell autoimmunity in a mouse model of type 1 diabetes.
TITLE: Priming and effector dependence on insulin B:9?23 peptide in NOD islet autoimmunity
(
Diabetes :: Triggering the autoimmune response against islets in type 1 diabetes published at
SpiritIndia on Tuesday, July 3, 2007)
Search more information on
DiabetesRecently posted related articles on Diabetes :
- Diabetes :: 63 percent of diabetics risk serious foot problems by wearing the wrong-sized shoes
- Diabetes :: India to launch special programme to control diabetes
- Diabetes :: Stanford researchers shed light on gestational diabetes
- Diabetes :: The new source of islet cells
- Diabetes :: European Medicine Agency confirms positive Avandia benefit risk assessment
- Pancreatitis :: Diabetes drug Byetta, exenatide may cause acute pancreatitis
- Diabetes :: PGC-1-alpha helps skeletal muscle and pancreatic islets communicate
- Blood Pressure :: Women with high or increasing blood pressure are up to three times more likely to develop diabetes
- Diabetes :: New IDF guidelines raise importance of post-meal glucose control
- Diabetes :: Solving a critical part of the insulin puzzle
»»
Migraine :: Teenagers from low income families at greater risk of migraine««
Anemia :: Recombinant Hemojuvelin protein - a treatment option for anemiaThe information provided on
SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information.
Health,
Business,
Science,
Sports,
Entertainment,
Technology
©2002-2009 SpiritIndia.com